Peter Nicol

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Klas Malmberg, Lars Rydén, Suad Efendić et al. · Journal of the American College of Cardiology · 1995 · 1.6K citations

Medicine, Cardiology, Internal Medicine +11

A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism

Sam Schulman, Ann-Sofie Rhedin, Per Lindmarker et al. · New England Journal of Medicine · 1995 · 941 citations

Medicine, Hematology, Pharmacotherapy +12

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism

Sam Schulman, S. Granqvist, Margareta Holmström et al. · New England Journal of Medicine · 1997 · 611 citations · Full text

Medicine, Hematology, Pharmacotherapy +12